Dexcare Closes $75M In Series C Funding, Led By Iconiq Growth, To Accelerate Market Expansion Of Its Care Access Platform
Dexcare Closes $75M In Series C Funding, Led By Iconiq Growth, To Accelerate Market Expansion Of Its Care Access Platform
06/21/23, 1:05 PM
Location
seattleMoney raised
$75 million
Industry
health care
Round Type
series c
Investors
Iconiq Growth
DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access. The new funding brings the total raised to $146 million, including two oversubscribed rounds closed in less than two years.
Company Info
Location
seattle, washington, united states
Additional Info
DexCare is on a mission to expand access to care for everyone. Our platform extends limited health-system capacity to ensure patients are matched to the right provider, at the right time, and in the right setting. And everything we do is rooted in data intelligence. Health systems rely on DexCare to achieve the operational clarity to best-utilize clinician hours, to intelligently navigate consumers to care, and to regain cost controls for sustainable growth. Today, DexCare serves more than 57 million patients across 50 states, and partners with leading U.S. health systems, including Kaiser Permanente, Providence, and Community Health Network. Join us, as we usher in a new era of digital-care access, where health systems can track and deliver every hour of capacity and where consumers can get care with digital ease.